Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials-Reference-Cited by-同舟云学术

Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials

Published:2017-06-20 Issue:9 Volume:19 Page:1233-1241
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Monami Matteo¹^ORCID,Nreu Besmir¹,Scatena Alessia²,Cresci Barbara¹,Andreozzi Francesco²³,Sesti Giorgio²³,Mannucci Edoardo¹

Affiliation:

1. Department of DiabetologyAzienda Ospedaliero Universitaria Careggi and University of Florence Florence Italy

2. Diabetology UnitOsperdale San Donato Arezzo Arezzo Italy

3. Department of Medical and Surgical SciencesUniversity Magna Graecia of Catanzaro Catanzaro Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12926

Reference41 articles.

1. A Critical Analysis of the Clinical Use of Incretin-Based Therapies

2. Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

3. Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model

4. Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study

5. Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Very Rare Cause of Markedly Elevated CA 19-9: Glucagon-like Peptide-1 Receptor Agonists;Diabetes & Metabolism;2024-09

2. Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance;International Journal of Molecular Sciences;2024-08-08

3. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis;Clinical Gastroenterology and Hepatology;2024-08

4. Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer;Frontiers in Pharmacology;2024-07-22

5. A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version);Journal of Diabetes Investigation;2024-07-11